{"entity":{"type":"insider","cik":"0001752955","url":"/insider/0001752955","json_url":"/insider/0001752955.json","name":"BRAENDER LORI J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2018-11-29","last":"2026-03-11","span_basis":"filed_date"},"name_variants":[{"name":"BRAENDER LORI J","source":"filing","n_filings":5,"first_seen":"2018-11-29","last_seen":"2026-03-11"}],"transactions":[{"id":5774466,"accession":"0001214659-26-003145","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-26-003145","line_url":"/filing/0001214659-26-003145#line-2","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001752955","owner_name":"BRAENDER LORI J","owner_display_name":"BRAENDER LORI J","owner_url":"/insider/0001752955","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40102.0,"shares_display":"40,102","price_per_share":4.173,"price_display":"4.17","price_state":"stated","total_value":167345.646,"total_display":"167,345.65","total_whole":"167,346","shares_owned_after":442879.0,"shares_owned_after_display":"442,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-11","scope":"insider"},{"id":6461136,"accession":"0001628280-22-016871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-016871","line_url":"/filing/0001628280-22-016871#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001752955","owner_name":"BRAENDER LORI J","owner_display_name":"BRAENDER LORI J","owner_url":"/insider/0001752955","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13761.0,"shares_display":"13,761","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":13210.56,"total_display":"13,210.56","total_whole":"13,211","shares_owned_after":38761.0,"shares_owned_after_display":"38,761","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-10","scope":"insider"},{"id":2977731,"accession":"0001214659-20-002747","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-20-002747","line_url":"/filing/0001214659-20-002747#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001752955","owner_name":"BRAENDER LORI J","owner_display_name":"BRAENDER LORI J","owner_url":"/insider/0001752955","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":1.5446,"price_display":"1.54","price_state":"stated","total_value":21624.4,"total_display":"21,624.40","total_whole":"21,624","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"},{"id":7793203,"accession":"0001214659-19-005183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-19-005183","line_url":"/filing/0001214659-19-005183#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001752955","owner_name":"BRAENDER LORI J","owner_display_name":"BRAENDER LORI J","owner_url":"/insider/0001752955","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.0747,"price_display":"4.07","price_state":"stated","total_value":40747.0,"total_display":"40,747.00","total_whole":"40,747","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-13","scope":"insider"},{"id":6511713,"accession":"0001140361-18-044032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-044032","line_url":"/filing/0001140361-18-044032#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001752955","owner_name":"BRAENDER LORI J","owner_display_name":"BRAENDER LORI J","owner_url":"/insider/0001752955","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.57,"price_display":"10.57","price_state":"stated","total_value":10570.0,"total_display":"10,570.00","total_whole":"10,570","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-27","filed_date":"2018-11-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001398733","name":"Aquestive Therapeutics, Inc.","url":"/issuer/0001398733","role":"Officer (Chief Legal Officer)","n_filings":5,"first_seen":"2018-11-29","last_seen":"2026-03-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001752955","retrieved_at":"2026-08-26T20:12:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}